(SeeNews) - Aug 5, 2011 - US biofuel and biotechnology firm Solazyme (NASDAQ:SZYM) saw its second-quarter net loss expand to USD 17 million (EUR 12m) from USD 6.4 million a year earlier due to higher expenses and one-off charges.